Search

A series of new 5-(arylidene/heteroarylidene)-2-(morpholinoimino)-3-phenylthiazolidin-4-ones (3–30) was synthesized. Cytotoxic effectiveness of these products was done against three cancerous cell lines (MCF-7, HepG-2, and SKOV-3) by standard SRB method. Fortunately, compounds 5, 7, 11, 12, 17, and 18 were found to be the most active against all the tested cell lines, comparable to doxorubicin. Apoptosis was determined using flow cytometry along with cell cycle analysis and supported by a molecular docking. The products 5, 7, and 12 induced a significant early-and late-apoptotic effect against all tumor cells while the products 5, 7, 11, and 12 significantly arrested all cancer cells in the S and G2 phases. Finally, a molecular docking was attempted to investigate the binding mode of the identified compounds 5 and 7 in with VEGFR-2-KDR receptor.

Some novel phosphorus compounds of types 1,2-benzoxaphosphinines, phospholo-[3,4-b][1]benzofuran, and chromonyl/coumarinyl/indenonyl phosphonates were achieved. The methodology depended on reaction of 1-(2-hydroxyphenyl)-3-phenylpropane-1,3-dione (1) with diethyl phosphite in the absence and presence of electrophilic reagent. Reaction of substrate 1 with diethyl phosphite in the presence of a base afforded 3-benzoyl-4-hydroxy-2-oxido-2H-1,2-benzoxaphosphinine (2), white its reaction with diethyl phosphite in the presence of ammonia, formaldehyde and chloroacetyl chloride under basic conditions gave the corresponding 4-ethoxy-4-oxido-2-phenyl-3,4-dihydro[1,2]benzoxaphosphinino[3,4-b] pyrrole (6) and 1-benzoyl-2-ethoxy-3-hydroxy-2-oxido-2H-phospholo[3,4-b][1]benzofuran (7), respectively. In addition, treatment of compound 1 with diethyl phosphite in the presence of DMFDMA, ethyl chloroacetate and oxalyl chloride under the same conditions led to the formation of chromonyl/coumarinyl/indenonyl phosphonates 3, 8, and 10, respectively, in moderate yields. The reaction mechanisms for the formation of these products were presented and explained. The molecular structures of products were deduced by spectral and analytical tools. The antimicrobial activity for the novel products were evaluated. The antimicrobial results were supported by SwissADME server based in silico computations. Both products 6 and 10 showed excellent antimicrobial properties.

An effective green one-pot and catalyst-free synthesis of a series of novel 5-(thiophene-2-carbonyl)-6-(trifluoromethyl)pyrano[2,3-c]pyrazoles and 6-(thiophene-2-carbonyl)-7-(trifluoromethyl)pyrano[2,3-d]pyrimidines bearing chromone ring was achieved. The method depended on a one-pot three-component reaction of readily available starting materials 4-oxo-4H-chromene-3-carboxaldehyde, 2-thenoyltrifluoroacetone, and cyclic active methylene compounds in water as solvent. The targeted compounds were assessed for their in vitro anticancer activity against mammary gland breast cancer cell line (MCF-7), liver cancer (HepG-2), and human colon cancer (HCT-116) by using sulphorhodamine B assay (SRB) method, while doxorubicin, was utilized as standard reference drug. Compounds 4a, 4c, and 6b exhibited excellent anticancer activity versus all cancer cell lines with IC50 values ranging from 1.7 to 9.9 ��g/mL.

The chemical reactivity of 3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one (1) towards some phosphorus reagents was studied. The enaminone 1 was cyclized into diethyl 2-phosphonochromone 2 via its treatment with diethyl phosphite in basic medium. However, its reaction with triethoxy phosphonoacetate gave the substituted pyrone phosphonate 3. In addition, two novel examples of 4-(dimethylamino)-6-(2-hydroxyphenyl)-2-sulfido-4H-1,3,2-oxathia-phosphinines 6 and 7 were obtained from treatment of enaminone 1 with O,O-diethyl dithiophosphoric acid and Lawesson’s reagent. When enaminone 1 was also treated with phosphorus decasulfide, it was turned into 4H-thiochromene-4-thione while its treatment with phosphorus tribromide, phosphorus oxychloride, or phenylphosphonic dichloride, 4H-4-oxo-chromene was isolated in all cases. The possible reaction mechanisms of the formation of these products were discussed. The structures of newly isolated products were established by elemental analysis and spectral tools.

The synthesis of some novel chromonyl and pyrazolyl α-aminophosphonates containing a quinazolinone ring was carried out by applying Pudovik and Kabachnik-Fields reactions under solvent- and catalyst-free conditions. The anticancer activities of these compounds were evaluated against five cancer cell lines. 3-{[(3-Phenyl/1,3-diphenyl-1H-pyrazol-4-yl)methylidene]amino}-2-phenyl-quinazolin-4(3H)-ones (3d,e) and diethyl {[3-phenyl/1,3-diphenyl-1H-pyrazol-4-yl][(4-oxo-2-phenyl-quinazolin-3(4H) yl)amino] methyl}phosphonates (4d,e) displayed the potent anticancer activities against HCT116, MCF-7 and HepG2 cell lines in comparison with the standard drug.

A convenient synthetic approach leading to synthesize a series of novel substituted azoles, azines and azepines linked to α -aminophosphonate moiety was achieved. The methodology depends on ring-opening and ring-closure (RORC) of chromone ring of diethyl chromonyl α -aminophosphonate 1via its reaction with nitrogen nucleophiles such as primary amines, 1,2-, 1,3- and 1,4-bi-nucleophiles in ethanolic sodium ethoxide. Also, treatment of compound 1 with some acyclic and cyclic active methylene compounds under the same reaction conditions afforded interesting novel isolated and fused pyridine systems bearing phosphonate groups at α -position. The screening of antimicrobial activity for the synthesized compounds indicates that connection of pyrazole, oxazepine and benzodiazepine rings with α -aminophosphonate moiety exhibited good antimicrobial effects. Also, evaluation of their antioxidant properties exemplifies that the compounds having 1,5-benzoxazepinyl and 1,5-benzodiazepinyl units in combination with α-amino-phosphonic diester moiety are the most powerful antioxidant agents.

A convenient synthetic approach leading to a series of novel substituted azoles, azines, and azepines linked to the α-aminophosphonate moiety was achieved. The methodology depends on ring opening and ring closure (RORC) of the chromone ring of diethyl chromonyl α-aminophosphonate 1 via its reaction with nitrogen nucleophiles such as primary amines and 1,2-, 1,3-, and 1,4-bi-nucleophiles in ethanolic sodium ethoxide. Also, treatment of compound 1 with some acyclic and cyclic active methylene compounds under the same reaction conditions afforded interesting novel isolated and fused pyridine systems bearing phosphonate groups at the α-position. The screening of antimicrobial activity for the synthesized compounds indicates that connection of pyrazole, oxazepine, and benzodiazepine rings with α-aminophosphonate moiety exhibited good antimicrobial effects. Also, evaluation of their antioxidant properties shows that the compounds having 1,5-benzoxazepinyl and 1,5-benzodiazepinyl units in combination with α-aminophosphonic diester moiety are the most powerful antioxidant agents.